Positioning Biobanking Assets for Maximum Value Leveraging the Precision Medicine Opportunity for Biobanks.

As therapies and assays continue to migrate towards precision medicine, so too must the traditional biobanking model, which is a key component in the supply of both physical samples and the data necessary to achieve patient-specific treatments. As precision medicine grows, so, too, does demand for biobanking services, offering both strategic and financial investors a significant opportunity for value creation.

In this white paper, learn how to evaluate biobank platforms and develop growth strategies that leverage the market shift towards precision medicine.

What’s Inside

• Components of the Biobanking Value Continuum
• The two main pathways from biobanking to precision medicine
• Case study: Traditional Biobanking Broker Platform